Terminated
ENVISION - NCT05310071 A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Please note, some trial-specific information on this page is sourced from clinicaltrials.gov.

About

Trial summary
TYPE INTERVENTIONAL
PHASE
Alternative text for Phase image

Phase

Clinical trials are done in different phases (0-4). Each phase provides important information about the drug. If a drug does not pass a particular phase, it cannot progress to the next phase. Visit the About Clinical Trials page to learn more.

PHASE3
CONDITION
  • Alzheimer's Disease
  • INTERVENTIONS
    Interventions tooltip icon

    Interventions

    The drug, device, or procedure being tested.

      DRUG:Aducanumab
      Administered as specified in the treatment arm.
      DRUG:Placebo
      Administered as specified in the treatment arm.
    ENROLLMENT
    Icon tooltip

    Enrollment

    The number of participants needed to take part in this trial.

    1027 participants
    (ACTUAL)
    60 Years to 85 Years
    (ADULT, OLDER ADULT)
    LOCATIONS 265
    Key dates
    Alternative text for Keydates image

    Key dates

    When the trial is conducted - from the date the first participant is enrolled to the date of the last participants's final visit.

    June 02, 2022
    Trial start date
    August 12, 2024
    Trial end date
    More Information
    OTHER STUDY IDs
      221AD305

      2022-001671-14

    Clinical Trials Gov ID NCT05310071
    Last Updated

    We are currently unable to share site locations for this clinical trial. Please use the link to view (or find) site locations:

    CLINICALTRIALS.GOV

    Results

    Results from this trial have been made available. Some information may be redacted (edited) to protect privacy, publication rights, and confidential commercial information. To review the information please visit biogentrialtransparency.com.

    PDF
    Clinical trial registers

    Clinical trial registers, like clinicaltrials.gov, provide information about registered clinical trials. 

     

    Publishing results for completed clinical trials on clinical trial registers help us share information about our clinical research. The results we publish here are written for healthcare professionals.

    CLINICALTRIALS.GOV
    Contact Us

    Please contact a clinical trial site directly to learn more about the trial. If no contact details are available, or for general inquiries, please contact the Biogen Clinical Trial Center.

    United States Biogen Clinical Trial Center

    866-633-4636

    clinicaltrials@biogen.com

    Find a trial location